Krsnaa Diagnostics Limited (KRSNAA) - Total Assets
Based on the latest financial reports, Krsnaa Diagnostics Limited (KRSNAA) holds total assets worth Rs15.07 Billion INR (≈ $162.94 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See KRSNAA total equity for net asset value and shareholders' equity analysis.
Krsnaa Diagnostics Limited - Total Assets Trend (2017–2025)
This chart illustrates how Krsnaa Diagnostics Limited's total assets have evolved over time, based on quarterly financial data.
Krsnaa Diagnostics Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
Krsnaa Diagnostics Limited's total assets of Rs15.07 Billion consist of 32.3% current assets and 67.7% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 0.3% |
| Accounts Receivable | Rs2.78 Billion | 21.7% |
| Inventory | Rs294.76 Million | 2.3% |
| Property, Plant & Equipment | Rs0.00 | 0.0% |
| Intangible Assets | Rs29.49 Million | 0.2% |
| Goodwill | Rs0.00 | 0.0% |
Asset Composition Trend (2017–2025)
This chart illustrates how Krsnaa Diagnostics Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is Krsnaa Diagnostics Limited worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Krsnaa Diagnostics Limited's current assets represent 32.3% of total assets in 2025, an increase from 17.2% in 2017.
- Cash Position: Cash and equivalents constituted 0.3% of total assets in 2025, down from 4.1% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2017.
- Asset Diversification: The largest asset category is accounts receivable at 21.7% of total assets.
Krsnaa Diagnostics Limited Competitors by Total Assets
Key competitors of Krsnaa Diagnostics Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$17.03 Billion |
|
Eurofins-Cerep SA
PA:ALECR
|
France | €84.58 Million |
|
Inoviq Ltd
AU:IIQ
|
Australia | AU$24.52 Million |
|
Bcal Diagnostics Ltd
AU:BDX
|
Australia | AU$7.17 Million |
|
Imagion Biosystems Ltd
AU:IBX
|
Australia | AU$932.48K |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
|
Monash Ivf Group Ltd
AU:MVF
|
Australia | AU$510.21 Million |
Krsnaa Diagnostics Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.42 | 1.09 | 1.18 |
| Quick Ratio | 1.34 | 1.01 | 1.15 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Rs1.69 Billion | Rs361.78 Million | Rs328.32 Million |
Krsnaa Diagnostics Limited - Advanced Valuation Insights
This section examines the relationship between Krsnaa Diagnostics Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.35 |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | 9.4% |
| Total Assets | Rs12.82 Billion |
| Market Capitalization | $206.54 Million USD |
Valuation Analysis
Below Book Valuation: The market values Krsnaa Diagnostics Limited's assets below their book value (0.02x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Krsnaa Diagnostics Limited's assets grew by 9.4% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Krsnaa Diagnostics Limited (2017–2025)
The table below shows the annual total assets of Krsnaa Diagnostics Limited from 2017 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | Rs12.82 Billion ≈ $138.60 Million |
+9.36% |
| 2024-03-31 | Rs11.72 Billion ≈ $126.74 Million |
+28.80% |
| 2023-03-31 | Rs9.10 Billion ≈ $98.40 Million |
+3.85% |
| 2022-03-31 | Rs8.76 Billion ≈ $94.75 Million |
+44.93% |
| 2021-03-31 | Rs6.05 Billion ≈ $65.38 Million |
-4.04% |
| 2020-03-31 | Rs6.30 Billion ≈ $68.13 Million |
+19.09% |
| 2019-03-31 | Rs5.29 Billion ≈ $57.21 Million |
+79.74% |
| 2018-03-31 | Rs2.94 Billion ≈ $31.83 Million |
+67.58% |
| 2017-03-31 | Rs1.76 Billion ≈ $18.99 Million |
-- |
About Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited provides diagnostic services in India. It offers a range radiology services, including computed tomography scans, magnetic resonance imaging, X-rays, and ultrasound and advanced imaging; pathology services, such as laboratory, and home collection and preventive health; and teleradiology and telepathology services. The company also provides other diagnostics services, su… Read more